Drawing for TESA

USPTO serial 90287041

TESA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KLUWE, CHERYL D
Law office
TMO LAW OFFICE 100 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TESA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory B. Phillips

Gregory B. Phillips KNOBBE MARTENS OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
038Providing on-line and social media chat rooms for transmission of messages among computer users in the fields of disease prevention, identification, and treatment relating to urological, metabolic, urinary tract systems, bladder, and reproductive organ diseases, disorders, pathologies, and medical conditions; Peer-to-peer network computer services, namely, electronic transmission of audio, video, data and documents among computers, relating to preventing, identifying and treating urological, metabolic, urinary tract systems, bladder, and reproductive organ diseases, disorders, pathologies, and medical conditions; Providing on-line and social media chat rooms for transmission of messages among computer users in the fields of biological and pharmaceutical preparations; Peer-to-peer network computer services, namely, electronic transmission of audio, video, data and documents among computers relating to the fields of biological and pharmaceutical preparationsABANDONED—
044Provision of health information and medical information all for treatment and diagnostic purposes in the fields of urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions for medical purposes; Provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, conditions, disorders and pathologies in the fields of urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions for medical purposes; Providing educational information in the fields of preventing, identifying and treating urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions for medical purposes; Providing health care advice and medical advice in the fields of preventing, identifying and treating urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions; Providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical purposes; none of the foregoing in connection with cancer treatment and immunotherapy servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2022PC.DPETITION TO DIRECTOR DISMISSED—
Mar 17, 2022APETASSIGNED TO PETITION STAFF—
Mar 16, 2022TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Feb 4, 2022MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Feb 4, 2022ABN5ABANDONMENT - AFTER PUBLICATION—
Feb 3, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 29, 2021DOCKASSIGNED TO EXAMINER—
Sep 17, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 12, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2021DOCKASSIGNED TO EXAMINER—
Mar 4, 2021AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 2, 2021ALIEASSIGNED TO LIE—
Dec 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 2, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance